DNA Methylation and Cancer Diagnosis

被引:130
作者
Delpu, Yannick [1 ,2 ]
Cordelier, Pierre [1 ,2 ]
Cho, William C. [3 ]
Torrisani, Jerome [1 ,2 ]
机构
[1] Canc Res Ctr Toulouse Inserm UMR 1037, F-31432 Toulouse 4, France
[2] Univ Toulouse 3, F-31062 Toulouse 9, France
[3] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China
关键词
DNA methylation; biomarkers; cancer diagnosis; DNA methylation inhibitors; clinical trials; ACUTE-MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR GENES; SPORADIC COLORECTAL-CANCER; GLUTATHIONE-S-TRANSFERASE; ABERRANT P16 METHYLATION; SQUAMOUS-CELL CARCINOMA; CPG ISLAND METHYLATION; DE-NOVO METHYLATION; BREAST-CANCER; PROMOTER HYPERMETHYLATION;
D O I
10.3390/ijms140715029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA methylation is a major epigenetic modification that is strongly involved in the physiological control of genome expression. DNA methylation patterns are largely modified in cancer cells and can therefore be used to distinguish cancer cells from normal tissues. This review describes the main technologies available for the detection and the discovery of aberrantly methylated DNA patterns. It also presents the different sources of biological samples suitable for DNA methylation studies. We discuss the interest and perspectives on the use of DNA methylation measurements for cancer diagnosis through examples of methylated genes commonly documented in the literature. The discussion leads to our consideration for why DNA methylation is not commonly used in clinical practice through an examination of the main requirements that constitute a reliable biomarker. Finally, we describe the main DNA methylation inhibitors currently used in clinical trials and those that exhibit promising results.
引用
收藏
页码:15029 / 15058
页数:30
相关论文
共 157 条
[1]   DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update [J].
Anglim, Paul P. ;
Alonzo, Todd A. ;
Laird-Offringa, Ite A. .
MOLECULAR CANCER, 2008, 7 (1)
[2]   Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin [J].
Bachman, KE ;
Rountree, MR ;
Baylin, SB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :32282-32287
[3]   Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis [J].
Belinsky, SA ;
Nikula, KJ ;
Palmisano, WA ;
Michels, R ;
Saccomanno, G ;
Gabrielson, E ;
Baylin, SB ;
Herman, JG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11891-11896
[4]   Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer [J].
Belinsky, SA ;
Nikula, KJ ;
Baylin, SB ;
Issa, JPJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4045-4050
[5]   Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma [J].
Bennett, Kristi L. ;
Karpenko, Matthew ;
Lin, Mau-ting ;
Claus, Rainer ;
Arab, Khelifa ;
Dyckhoff, Gerhard ;
Plinkert, Peter ;
Herpel, Esther ;
Smiraglia, Dominic ;
Plass, Christoph .
CANCER RESEARCH, 2008, 68 (12) :4494-4499
[6]   Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry [J].
Berdasco, Maria ;
Esteller, Manel .
DEVELOPMENTAL CELL, 2010, 19 (05) :698-711
[7]   Reprogramming towards pluripotency requires AID-dependent DNA demethylation [J].
Bhutani, Nidhi ;
Brady, Jennifer J. ;
Damian, Mara ;
Sacco, Alessandra ;
Corbel, Stephane Y. ;
Blau, Helen M. .
NATURE, 2010, 463 (7284) :1042-U57
[8]   High-throughput DNA methylation profiling using universal bead arrays [J].
Bibikova, M ;
Lin, ZW ;
Zhou, LX ;
Chudin, E ;
Garcia, EW ;
Wu, B ;
Doucet, D ;
Thomas, NJ ;
Wang, YH ;
Vollmer, E ;
Goldmann, T ;
Seifart, C ;
Jiang, W ;
Barker, DL ;
Chee, MS ;
Floros, J ;
Fan, JB .
GENOME RESEARCH, 2006, 16 (03) :383-393
[9]   DNA methylation patterns and epigenetic memory [J].
Bird, A .
GENES & DEVELOPMENT, 2002, 16 (01) :6-21
[10]   hMLH1 promoter hypermethylation and MSI status in human endometrial carcinomas with and without metastases [J].
Bischoff, J. ;
Ignatov, A. ;
Semczuk, A. ;
Schwarzenau, C. ;
Ignatov, T. ;
Krebs, T. ;
Kuester, D. ;
Przadka-Rabaniuk, D. ;
Roessner, A. ;
Costa, S. D. ;
Schneider-Stock, R. .
CLINICAL & EXPERIMENTAL METASTASIS, 2012, 29 (08) :889-900